Do We Need Treatment With Tumour Necrosis Factor Blockers for Giant Cell Arteritis?

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.2007.086330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Giant Cell Arteritis Presenting as Scalp Necrosis

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2011English

Endovascular Treatment of Intracerebral Giant Cell Arteritis

Frontiers in Neurology
Neurology
2020English

Uncommon Presentation of Giant Cell Arteritis: Report of Two Cases With Scalp Necrosis

Neurology India
Neurology
2009English

Giant Cell Arteritis.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1991English

Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Treatment of Polymyalgia Rheumatica and Giant Cell Arteritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1990English

Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated With Etanercept – A Tumour Necrosis Factor-Alpha Antagonist

Canadian Journal of Gastroenterology
2001English

Weight Loss and Achievement of Minimal Disease Activity in Patients With Psoriatic Arthritis Starting Treatment With Tumour Necrosis Factor Α Blockers

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

Secondary Amyloidosis in Crohn's Disease: Treatment With Tumour Necrosis Factor Inhibitor

Gut
Gastroenterology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy